The Patent Finder

Heterocyclic Compounds as Bet Inhibitors

Nuvation Bio Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,584,756Heterocyclic Compounds as Bet Inhibitors
In force
 · High confidence
Nuvation Bio Inc.In forceHigh confidence
Application 18/152,049Heterocyclic Compounds as Bet Inhibitors
Abandoned
Abandoned Oct 16, 2024
Nuvation Bio Inc.AbandonedAbandoned Oct 16, 2024
Application 18/915,226Heterocyclic Compounds as Bet Inhibitors
Pending
Not granted
Nuvation Bio Inc.PendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Nuvation Bio Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited